These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16432664)

  • 41. Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India.
    Ambroise M; Ghosh M; Mallikarjuna VS; Kurian A
    Asian Pac J Cancer Prev; 2011; 12(3):625-9. PubMed ID: 21627355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Study on breast carcinoma Her2/neu and hormonal receptors status assessed by automated images analysis systems: ACIS III (Dako) and ScanScope (Aperio).
    Słodkowska J; Filas V; Buszkiewicz E; Trzeciak P; Wojciechowski M; Koktysz R; Staniszewski W; Breborowicz J; Rojo MG
    Folia Histochem Cytobiol; 2010 Jan; 48(1):19-25. PubMed ID: 20529811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histologic grade, stage, and survival in breast carcinoma: comparison of African American and Caucasian women.
    Henson DE; Chu KC; Levine PH
    Cancer; 2003 Sep; 98(5):908-17. PubMed ID: 12942556
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer.
    Huang HJ; Neven P; Drijkoningen M; Paridaens R; Wildiers H; Van Limbergen E; Berteloot P; Amant F; Vergote I; Christiaens MR
    J Clin Pathol; 2005 Jun; 58(6):611-6. PubMed ID: 15917412
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early onset of breast carcinoma in African American women with poor prognostic factors.
    Aziz H; Hussain F; Sohn C; Mediavillo R; Saitta A; Hussain A; Brandys M; Homel P; Rotman M
    Am J Clin Oncol; 1999 Oct; 22(5):436-40. PubMed ID: 10521053
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of HER-2/neu overexpression with the number of involved axillary lymph nodes in hormone receptor positive breast cancer patients.
    Tokatli F; Altaner S; Uzal C; Ture M; Kocak Z; Uygun K; Bilgi S
    Exp Oncol; 2005 Jun; 27(2):145-9. PubMed ID: 15995634
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multicentric mammary carcinoma: evidence of monoclonal proliferation.
    Middleton LP; Vlastos G; Mirza NQ; Eva S; Sahin AA
    Cancer; 2002 Apr; 94(7):1910-6. PubMed ID: 11932891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component.
    Brower ST; Ahmed S; Tartter PI; Bleiweiss I; Amberson JB
    Ann Surg Oncol; 1995 Sep; 2(5):440-4. PubMed ID: 7496840
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential association of cytochrome P450 3A4 genotypes with onsets of breast tumors in African American versus Caucasian patients.
    McDaniel DO; Thurber T; Lewis-Traylor A; Berry C; Barber WH; Zhou X; Bigler S; Vance R
    J Investig Med; 2011 Oct; 59(7):1096-103. PubMed ID: 21750466
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does race predict survival for women with invasive breast cancer?
    Walsh SM; Zabor EC; Stempel M; Morrow M; Gemignani ML
    Cancer; 2019 Sep; 125(18):3139-3146. PubMed ID: 31206623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes: Retrospective-Observational Analytical Study.
    Shokouh TZ; Ezatollah A; Barand P
    Medicine (Baltimore); 2015 Aug; 94(32):e1359. PubMed ID: 26266392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa.
    Awadelkarim KD; Arizzi C; Elamin EO; Hamad HM; De Blasio P; Mekki SO; Osman I; Biunno I; Elwali NE; Mariani-Costantini R; Barberis MC
    Histopathology; 2008 Mar; 52(4):445-56. PubMed ID: 18315597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Her-2 prognostic value in very early-stage breast cancer: a single-institution retrospective analysis.
    Sanpaolo P; Barbieri V; Pedicini P; Fusco V
    Med Oncol; 2012 Jun; 29(2):459-65. PubMed ID: 21359639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Steroid hormone receptor association with prognostic markers in breast carcinoma in Northern Pakistan.
    Sharif MA; Mamoon N; Mushtaq S; Khadim MT; Jamal S
    J Coll Physicians Surg Pak; 2010 Mar; 20(3):181-5. PubMed ID: 20392381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry.
    Zell JA; Tsang WY; Taylor TH; Mehta RS; Anton-Culver H
    Breast Cancer Res; 2009; 11(1):R9. PubMed ID: 19228416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
    Grann VR; Troxel AB; Zojwalla NJ; Jacobson JS; Hershman D; Neugut AI
    Cancer; 2005 Jun; 103(11):2241-51. PubMed ID: 15844176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
    Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
    Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Breast cancer characteristics at diagnosis and survival among Arab-American women compared to European- and African-American women.
    Hensley Alford S; Schwartz K; Soliman A; Johnson CC; Gruber SB; Merajver SD
    Breast Cancer Res Treat; 2009 Mar; 114(2):339-46. PubMed ID: 18415013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Androgen Receptor and ALDH1 Expression Among Internationally Diverse Patient Populations.
    Jiagge E; Jibril AS; Davis M; Murga-Zamalloa C; Kleer CG; Gyan K; Divine G; Hoenerhoff M; Bensenhave J; Awuah B; Oppong J; Adjei E; Salem B; Toy K; Merajver S; Wicha M; Newman L
    J Glob Oncol; 2018 Oct; 4():1-8. PubMed ID: 30307804
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of nuclear factor-κB in female breast cancer: a study in Indian patients.
    Jana D; Das S; Sarkar DK; Mandal S; Maji A; Mukhopadhyay M
    Asian Pac J Cancer Prev; 2012; 13(11):5511-5. PubMed ID: 23317209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.